See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626199_2023_ALPINE_IMMUNE_SCIENCES_INC.pdf
Logs
Graph
Absolute values for 0001626199, ALPINE IMMUNE SCIENCES INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 240,993,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,584,000 |
| 3 | remainder_Assets | 44,109,000 |
| 4 | LiabilitiesCurrent | 57,996,000 |
| 5 | LiabilitiesNoncurrent | 49,270,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,968,000 |
| 9 | ResearchAndDevelopmentExpense | 70,243,000 |
| 10 | remainder_Expenses | 2,806,000 |
| 11 | remainder_Revenues | 30,064,000 |
| 12 | remainder_NetIncome | 3,191,000 |
| 13 | remainder_ComprehensiveNetIncome | -848,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 286,686,000 |
| 1 | Liabilities | 107,266,000 |
| 2 | Expenses | 91,017,000 |
| 3 | Revenues | 30,064,000 |
| 4 | StockholdersEquity | 179,420,000 |
| 5 | NetIncome | -57,762,000 |
| 6 | ComprehensiveNetIncome | -58,186,000 |
| 7 | BaseVar | 259,536,000 |
| 8 | EconomicCapitalRatio | 1.27 |